ICD code G70.01 is used to identify myasthenia gravis with acute exacerbation for accurate diagnosis and streamlined healthcare documentation.
ICD code G70.01 is myasthenia gravis with an acute exacerbation, meaning the patient has a sudden worsening of symptoms related to this chronic neuromuscular disorder.
1. Presence of fluctuating muscle weakness that worsens with activity and improves with rest
2. Evidence of acute worsening of previously diagnosed myasthenia gravis
3. Sudden increase in severity or frequency of symptoms such as ptosis, diplopia, dysphagia, dysarthria, or limb weakness
4. Onset of respiratory distress or difficulty breathing not attributable to other causes
5. Requirement for increased medical intervention, such as hospitalization, ventilatory support, or escalation of immunosuppressive therapy
6. Exclusion of alternative causes for symptom exacerbation, such as infection or medication side effects
Relevant CPT codes that may be used to treat ICD code G70.01 include:
- 96365: Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour
- 96366: Each additional hour (List separately in addition to code for primary procedure)
- 36415: Collection of venous blood by venipuncture
- 97110: Therapeutic exercises, each 15 minutes
- 99221-99223: Initial hospital care, per day, for the evaluation and management of a patient
- 99231-99233: Subsequent hospital care, per day, for the evaluation and management of a patient
- 99460-99462: Initial and subsequent hospital care for newborns (if applicable)
- 95860-95864: Electromyography (EMG) studies
- 95885-95887: Needle electromyography, each extremity
- 96372: Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular
CPT code selection should be based on the specific services rendered and clinical scenario.
Schedule a demo to see how MD Clarity’s RevFind software can automatically read your contracts and detect underpayments for CPT codes associated with ICD code G70.01. Ensure your organization is accurately reimbursed—discover how RevFind can help you identify missed revenue opportunities today.

